Albumin-bound paclitaxel as new treatment for metastatic cholangiocarcinoma: A case report

doi:10.5306/wjco.v11.i10.844

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7268)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

239

WORD

112

HTML

2887

Figures (1-6)

215

Tables (1-2)

241

Sum=3694

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

423

Download

786

Sum=1209

Publishing Process of This Article

Item

Count

Browse

1041

Download

1324

Sum=2365

Oct 24, 2020 (publication date) through May 19, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Oncol. Oct 24, 2020; 11(10): 844-853
Published online Oct 24, 2020. doi: 10.5306/wjco.v11.i10.844

Full Size Figure Download Figure

Figure 2 Evolution of CA19-9 blood levels (IU/mL). Yellow: CA19-9 levels of localized cholangiocarcinoma at diagnosis, after surgery, and during follow-up; Cyan: CA19-9 levels during FOLFOX treatment; Magenta: CA19-9 levels during albumin-bound paclitaxel treatment.

Citation: Martin Huertas R, Fuentes-Mateos R, Serrano Domingo JJ, Corral de la Fuente E, Rodríguez-Garrote M. Albumin-bound paclitaxel as new treatment for metastatic cholangiocarcinoma: A case report. World J Clin Oncol 2020; 11(10): 844-853
URL: https://www.wjgnet.com/2218-4333/full/v11/i10/844.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i10.844